SUBSCRIBE
SUBSCRIBE

Nevada

PRESS RELEASES
Press Releases
Zura Bio Announces Chief Financial Officer Transition
July 2, 2025
 · 
4 min read
Press Releases
BioVie Highlights Patient-Centric Design of SUNRISE-PD Trial at Advanced Therapeutics in Movement & Related Disorders® Congress (ATMRD)
June 26, 2025
 · 
10 min read
Press Releases
BioVie to Present Overview of Phase 2 SUNRISE-PD Trial at the Advanced Therapeutics in Movement & Related Disorders® Congress
June 25, 2025
 · 
8 min read
Press Releases
CGT Global Supports Renown Health in Advancing Breast Cancer Treatment in Nevada
June 9, 2025
 · 
1 min read
Press Releases
Secura Bio Announces First Patient Dosed in Phase 3 TERZO Study of COPIKTRA® (duvelisib) in Relapsed/Refractory Nodal T-follicular Helper Cell Lymphoma
June 9, 2025
 · 
5 min read
Press Releases
Avant Technologies and Partner, Ainnova, Finalizing Automated Retinal Camera Prototype Ahead of Full-Scale Development
June 4, 2025
 · 
4 min read
Press Releases
Zura Bio to Present at the Jefferies Global Healthcare Conference 2025
May 27, 2025
 · 
1 min read
Press Releases
Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000
May 21, 2025
 · 
3 min read
Press Releases
Zura Bio Launches Global Phase 2 TibuSHIELD Study to Evaluate Tibulizumab in Adults with Hidradenitis Suppurativa
May 20, 2025
 · 
9 min read
Press Releases
Nika Pharmaceuticals, Inc. (NIKA) Markets Analysis and €8.5 Billion Projected Revenue
May 19, 2025
 · 
3 min read
Press Releases
BioVie Enrolls First Patient in ADDRESS-LC Clinical Trial Assessing Novel Anti-Inflammatory Candidate Bezisterim for the Treatment of Neurological Symptoms Associated with Long COVID
May 15, 2025
 · 
9 min read
Press Releases
BioVie to Host Virtual KOL Event to Discuss the Phase 2 Study of Bezisterim for the Treatment of Parkinson’s Disease on May 28, 2025
May 15, 2025
 · 
10 min read
Press Releases
Avant Technologies and Ainnova Tech Begin Acquisition Talks Ahead of FDA Pre-Submission Meeting
May 12, 2025
 · 
5 min read
Press Releases
CB Scientific, Inc. (CBSC) Announces Corporate Name Change to Cardiac Biotech Solutions, Inc.
May 8, 2025
 · 
4 min read
Press Releases
Zura Bio Reports First Quarter 2025 Financial Results and Recent Corporate Updates
May 8, 2025
 · 
11 min read
Press Releases
BioVie to Present Rationale and Design of Phase 2 SUNRISE-PD Clinical Trial at the 30th World Congress on Parkinson’s Disease and Related Disorders (IAPRD 2025)
May 7, 2025
 · 
8 min read
Press Releases
BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth
May 6, 2025
 · 
11 min read
Press Releases
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo™ robotic-assisted surgery system
April 28, 2025
 · 
6 min read
Press Releases
Johnson & Johnson’s TAR-200 monotherapy achieves high disease-free survival of more than 80 percent in BCG-unresponsive, high-risk papillary NMIBC
April 28, 2025
 · 
10 min read
Press Releases
Johnson & Johnson’s TAR-200 monotherapy demonstrates highest complete response rate with sustained clinical benefits in patients with certain types of bladder cancer
April 28, 2025
 · 
9 min read
Load More